1. Neurological Manifestations and Outcomes in a Retrospective Cohort of Mexican Inpatients with SARS-CoV-2 Pneumonia: Design of a Risk Profile
- Author
-
Fidel Cerda-Téllez, Sandra Quiñonez-Aguilar, Rodrigo Alberto Rodríguez-Briseño, Sofia L. Alcaraz-Estrada, Ramón Mauricio Coral-Vázquez, Maribel Santosbeña-Lagunes, José A Merino-Rajme, Juan Antonio Suárez-Cuenca, Sandra Muñoz-López, Sergio Sauri-Suárez, Luis Montiel-López, Francisco Manuel Cuatepotzo-Burgos, Maricela Escarela-Serrano, Alberto Hilarión De la Vega-Bravo, Celia Mireya Rodríguez-Martínez, Adriana Balderrama-Soto, Christian Gabriel Toledo-Lozano, Silvia García, Paul Mondragón-Terán, Juan Antonio Pineda-Juárez, and María Del Carmen Méndez-Vidrio
- Subjects
medicine.medical_specialty ,Subarachnoid hemorrhage ,Leadership and Management ,Encephalopathy ,Health Informatics ,neurological symptoms ,Article ,Health Information Management ,respiratory infection ,Internal medicine ,Diabetes mellitus ,medicine ,Stroke ,Asthma ,business.industry ,Health Policy ,risk profile ,Respiratory infection ,case fatality ratio ,COVID-19 ,Retrospective cohort study ,medicine.disease ,Pneumonia ,Medicine ,business - Abstract
We analyzed the neurological manifestations in Mexican patients hospitalized with pneumonia due to COVID-19 and investigated the association between demographic, clinical, and biochemical variables and outcomes, including death. A retrospective, analytical study was conducted using the electronic records of patients hospitalized between 1 April 2020 and 30 September 2020. Records of 1040 patients were analyzed: 31.25% died and 79.42% had neurological symptoms, including headache (80.62%), anosmia (32.20%), ageusia (31.96%), myopathy (28.08%), disorientation (14.89%), encephalopathy (12.22%), neuropathy (5.4%), stroke (1.3%), seizures (1.3%), cerebral hemorrhage (1.08%), encephalitis (0.84%), central venous thrombosis (0.36%), and subarachnoid hemorrhage (0.24%). Patients also had comorbidities, such as hypertension (42.30%), diabetes mellitus (38.74%), obesity (61.34%), chronic obstructive pulmonary disease (3.17%), and asthma (2.01%). Factors associated with neurological symptoms were dyspnea, chronic obstructive pulmonary disease, advanced respiratory support, prolonged hospitalization, and worsening fibrinogen levels. Factors associated with death were older age, advanced respiratory support, amine management, chronic obstructive pulmonary disease, intensive care unit management, dyspnea, disorientation, encephalopathy, hypertension, neuropathy, diabetes, male sex, three or more neurological symptoms, and obesity grade 3. In this study we designed a profile to help predict patients at higher risk of developing neurological complications and death following COVID-19 infection.
- Published
- 2021